Ligand · MXD
MXD · 6-piperidin-1-ylpyrimidine-2,4-diamine 3-oxide
MXD, 6-piperidin-1-ylpyrimidine-2,4-diamine 3-oxide (C9 H15 N5 O, 209.2 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and…
- Component
- MXD
- Formula
- C9 H15 N5 O
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
MXD in 4 structures; the first of them:
- 3B6H · Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil · MXD A551 · binds TYR99, ALA100, LEU103, ALA283, THR284, ASN287
- 4K7A · Crystal structure of the androgen receptor ligand binding domain in complex with minoxidil · MXD A1002 · binds GLU793, TRP796, LEU797, TYR857, GLN858, LYS861
- 3B6H · Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil · MXD A551 · binds TYR99, ALA100, LEU103, ALA283, THR284, ASN287
- 4K7A · Crystal structure of the androgen receptor ligand binding domain in complex with minoxidil · MXD A1002 · binds GLU793, TRP796, LEU797, TYR857, GLN858, LYS861
Residues it binds most
ALA 4, LEU 6, TYR 6, ASN 4, THR 4, GLN 2, GLU 2, LYS 2, TRP 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.